Published: 2018-03-21

Assessment of carotid intima-media thickness in hypothyroidism and the effect of thyroid replacement therapy

Varun Vijayan, Jayasingh K., Jayaraman G., Siva Ranganathan Green, Deyagarasan E.


Background: Carotid artery intima-media thickness (CAIMT) measurement in hypothyroidism will help assess the progression of atherosclerosis and timely intervention may prevent vascular complications.

Methods: This study included 30 clinical hypothyroid (CH), 30 subclinical hypothyroid (SCH) and 30 euthyroid. As per procedure, informed consent was taken from the patients in prescribed formats before their participation in the study. Patients were divided into 3 groups of CHs, SCH and Controls after obtaining the thyroid function test values. CAIMT on the right side was measured in the three groups for comparison. Other parameters included age, sex, height, weight, body mass index (BMI), total cholesterol and triglycerides. After 4 months of levothyroxine therapy, CAIMT, total cholesterol and triglycerides were reassessed.

Results: The CAIMT was increased in CH and SCH group when compared to euthyroid individuals. The mean CAIMT in CH group was 0.60±0.009cm, in SCH group it was 0.055±0.010 cm and in controls it was 0.047±0.006 cm. After 4 months of levothyroxine therapy, there was no change observed in the mean CAIMT values.

Conclusions: CAIMT levels were increased in CH and SCH group when compared to euthyroid group. There was no regression of CAIMT after 4 months of levothyroxine therapy.


Carotid artery intima-media thickness, Clinical hypothyroidism, Subclinical hypothyroidism

Full Text:



Kumar AR. A study of Carotid Intima Medial thickness among Diabetic and non Diabetic patients and its association with the Vascular Complications - a Comparative Study. Int J Biol Med Res. 2013;4(54):3078-83.

Zhao T, Chen B, Zhou Y, Wang X, Zhang Y, Wang H, et al. Effect of levothyroxine on the progression of carotid intima-media thickness in subclinical hypothyroidism patients: a meta-analysis. BMJ Open. 2017;7(10):e016053.

Cappola AR, Ladenson PW. Hypothyroidism and Atherosclerosis. J Clin Endocrinol Metab. 2003;88(6):2438-44.

Khandelwal D, Tandon N. Overt and subclinical hypothyroidism: who to treat and how. Drugs. 2012;72(1):17-33.

Leskinen Y, Lehtimäki T, Loimaala A, Lautamatti V, Kallio T, Huhtala H, et al. Carotid atherosclerosis in chronic renal failure-the central role of increased plaque burden. Atherosclerosis. 2003;171(2):295-302.

Unnikrishnan A, Bantwal G, John M, Kalra S, Sahay R, Tewari N. Prevalence of hypothyroidism in adults: An epidemiological study in eight cities of India. Indian J Endocrinol Metab. 2013;17(4):647.

Maas Ahem, Appelman YEA. Gender differences in coronary heart disease. Neth Heart J. 2010;18(12):598-602.

Aziz Kma. Association of Hypothyroidism with Body Mass Index, Systolic Blood Pressure and Proteinuria in Diabetic Patients: Does treated Hypothyroidism with Thyroxine Replacement Therapy Prevent Nephropathy/Chronic Renal Disease? Curr Diabetes Rev. 2016;12(3):297-306.

Chu JW, Crapo LM. The treatment of subclinical hypothyroidism is seldom necessary. J Clin Endocrinol Metab. 2001;86(10):4591-9.

Fatourechi V. Subclinical Hypothyroidism: An Update for Primary Care Physicians. Mayo Clin Proc. 2009;84(1):65–71.

Liu X-L, He S, Zhang S-F, Wang J, Sun X-F, Gong C-M, et al. Alteration of Lipid Profile in Subclinical Hypothyroidism: A Meta-Analysis. Med Sci Monit Int Med J Exp Clin Res. 2014;20:1432-41.

Asranna A, Taneja RS, Kulshreshta B. Dyslipidemia in subclinical hypothyroidism and the effect of thyroxine on lipid profile. Indian J Endocrinol Metab. 2012;16(8):347.

Bandyopadhyay SK, Basu AK, Pal SK, Roy P, Chakrabarti S, Pathak HS, et al. A study on dyslipidaemia in subclinical hypothyroidism. J Indian Med Assoc. 2006;104(11):622-4.

Pearce EN, Wilson PWF, Yang Q, Vasan RS, Braverman LE. Thyroid Function and Lipid Subparticle Sizes in Patients with Short-Term Hypothyroidism and a Population-Based Cohort. J Clin Endocrinol Metab. 2008;93(3):888-94.

Rizos C, Elisaf M, Liberopoulos E. Effects of Thyroid Dysfunction on Lipid Profile. Open Cardiovasc Med J. 2011;5:76-84.

Singh K, Singh S. Alterations in Lipid Fraction Levels in Subclinical Hypothyroidism in North Indian Population. Indian J Fundam Appl Life Sci Online Int J Available. 2011;1:2231-6345.

Nikkilä EA, Kekki M. Plasma triglyceride metabolism in thyroid disease. J Clin Invest. 1972;51(8):2103-14.

Tanis BC, Westendorp RGJ, Smelt AHM. Effect of thyroid substitution on hypercholesterolaemia in patients with subclinical hypothyroidism: a reanalysis of intervention studies. Clin Endocrinol (Oxf). 1996;44(6):643-9.

Karoli R, Fatima J, Shukla V, Chandra A, Khanduri S, Rawat A. Hospital based study of carotid intima media thickness and high-sensitivity C-reactive protein in young hypothyroid patients. J Indian Acad Clin Med. 2014;15:116-9.

Gao N, Zhang W, Zhang Y, Yang Q, Chen S. Carotid intima-media thickness in patients with subclinical hypothyroidism: A meta-analysis. Atherosclerosis. 2013;227(1):18-25.

Polak JF, Pencina MJ, O’Leary DH, D’Agostino RB. Common carotid artery intima-media thickness progression as a predictor of stroke in multi-ethnic study of atherosclerosis. Stroke. 2011;42(11):3017–21.

Çakal E, Turgut AT, Demirbas B, Ozkaya M, Çakal B, Serter R, et al. Effects of L-thyroxine Replacement Therapy on Carotid Intima-media Thickness in Patients with Primary Hypothyroidism. Exp Clin Endocrinol Diabetes. 2009;117(06):294-300.

Delitala AP, Filigheddu F, Orrù M, AlGhatrif M, Steri M, Pilia MG, et al. no evidence of association between subclinical thyroid disorders and common carotid intima medial thickness or atherosclerotic plaque. Nutr Metab Cardiovasc Dis NMCD. 2015;25(12):1104-10.

Jorde R, Joakimsen O, Stensland E, Mathiesen EB. Lack of Significant Association between Intima-Media Thickness in the Carotid Artery and Serum TSH Level. The Tromsø Study. Thyroid. 2008;18(1):21–5.

Nagasaki T, Inaba M, Henmi Y, Kumeda Y, Ueda M, Tahara H, et al. Decrease in carotid intima-media thickness in hypothyroid patients after normalization of thyroid function. Clin Endocrinol (Oxf). 2003;59(5):607-12.